AAAAAA

   
Results: 1-25 | 26-38
Results: 1-25/38
Gazing into a crystal ball-cancer therapy in the post-genomic era
Authors: Ratain, MJ Relling, MV
Citation: Mj. Ratain et Mv. Relling, Gazing into a crystal ball-cancer therapy in the post-genomic era, NAT MED, 7(3), 2001, pp. 283-285
Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma
Authors: Ribeiro, RC Fletcher, BD Kennedy, W Harrison, PL Neel, MD Kaste, SC Sandlund, JT Rubnitz, JE Razzouk, BI Relling, MV Pui, CH
Citation: Rc. Ribeiro et al., Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma, LEUKEMIA, 15(6), 2001, pp. 891-897
International childhood Acute Lymphoblastic Leukemia workshop: Sausalito, CA, 30 November-1 December 2000
Authors: Pui, CH Sailan, S Relling, MV Masera, G Evans, WE
Citation: Ch. Pui et al., International childhood Acute Lymphoblastic Leukemia workshop: Sausalito, CA, 30 November-1 December 2000, LEUKEMIA, 15(5), 2001, pp. 707-715
Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine
Authors: Evans, WE Hon, YY Bomgaars, L Coutre, S Holdsworth, M Janco, R Kalwinsky, D Keller, F Khatib, Z Margolin, J Murray, J Quinn, J Ravindranath, Y Ritchey, K Roberts, W Rogers, ZR Schiff, D Steuber, C Tucci, F Kornegay, N Krynetski, EY Relling, MV
Citation: We. Evans et al., Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine, J CL ONCOL, 19(8), 2001, pp. 2293-2301
Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma
Authors: Pui, CH Mahmoud, HH Wiley, JM Woods, GM Leverger, G Camitta, B Hastings, C Blaney, SM Relling, MV Reaman, GH
Citation: Ch. Pui et al., Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma, J CL ONCOL, 19(3), 2001, pp. 697-704
The effect of atovaquone on etoposide pharmacokinetics in children with acute lymphoblastic leukemia
Authors: van de Poll, MEC Relling, MV Schuetz, EG Harrison, PL Hughes, W Flynn, PM
Citation: Mec. Van De Poll et al., The effect of atovaquone on etoposide pharmacokinetics in children with acute lymphoblastic leukemia, CANC CHEMOT, 47(6), 2001, pp. 467-472
Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemia
Authors: Blanco, JG Dervieux, T Edick, MJ Mehta, PK Rubnitz, JE Shurtleff, S Raimondi, SC Behm, FG Pui, CH Relling, MV
Citation: Jg. Blanco et al., Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemia, P NAS US, 98(18), 2001, pp. 10338-10343
Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cells
Authors: Dervieux, T Blanco, JG Krynetski, EY Vanin, EF Roussel, MF Relling, MV
Citation: T. Dervieux et al., Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cells, CANCER RES, 61(15), 2001, pp. 5810-5816
Pharmacodynamics in childhood acute lymphoblastic leukemia
Authors: Pui, CH Relling, MV Sandlund, JT Campana, D Evans, WE
Citation: Ch. Pui et al., Pharmacodynamics in childhood acute lymphoblastic leukemia, HEMAT BLOOD, 40, 2001, pp. 364-369
Thioguanine substitution alters DNA cleavage mediated by topoisomerase II
Authors: Krynetskaia, NF Cai, XJ Nitiss, JL Krynetski, EY Relling, MV
Citation: Nf. Krynetskaia et al., Thioguanine substitution alters DNA cleavage mediated by topoisomerase II, FASEB J, 14(14), 2000, pp. 2339-2344
Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia
Authors: McLeod, HL Krynetski, EY Relling, MV Evans, WE
Citation: Hl. Mcleod et al., Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia, LEUKEMIA, 14(4), 2000, pp. 567-572
Individualized methotrexate dosing in children with relapsed acute lymphoblastic leukemia
Authors: Wall, AM Gajjar, A Link, A Mahmoud, H Pui, CH Relling, MV
Citation: Am. Wall et al., Individualized methotrexate dosing in children with relapsed acute lymphoblastic leukemia, LEUKEMIA, 14(2), 2000, pp. 221-225
Glutathione S-transferase genotypes in children who develop treatment-related acute myeloid malignancies
Authors: Woo, MH Shuster, JJ Chen, C Bash, RO Behm, FG Camitta, B Felix, CA Kamen, BA Pui, CH Raimondi, SC Winick, NJ Amylon, MD Relling, MV
Citation: Mh. Woo et al., Glutathione S-transferase genotypes in children who develop treatment-related acute myeloid malignancies, LEUKEMIA, 14(2), 2000, pp. 232-237
Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital
Authors: Pui, CH Boyett, JM Rivera, GK Hancock, ML Sandlund, JT Ribeiro, RC Rubnitz, JE Behm, FG Raimondi, SC Gajjar, A Razzouk, B Campana, D Kun, LE Relling, MV Evans, WE
Citation: Ch. Pui et al., Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital, LEUKEMIA, 14(12), 2000, pp. 2286-2294
Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemia
Authors: Woo, MH Hak, LJ Storm, MC Sandlund, JT Ribeiro, RC Rivera, GK Rubnitz, JE Harrison, PL Wang, B Evans, WE Pui, CH Relling, MV
Citation: Mh. Woo et al., Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemia, J CL ONCOL, 18(7), 2000, pp. 1525-1532
Creation of polarized cells coexpressing CYP3A4, NADPH cytochrome P450 reductase and MDR1/P-glycoprotein
Authors: Brimer, C Dalton, JT Zhu, ZX Schuetz, J Yasuda, K Vanin, E Relling, MV Lu, Y Schuetz, EG
Citation: C. Brimer et al., Creation of polarized cells coexpressing CYP3A4, NADPH cytochrome P450 reductase and MDR1/P-glycoprotein, PHARM RES, 17(7), 2000, pp. 803-810
Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia
Authors: Relling, MV Pui, CH Sandlund, JT Rivera, GK Hancock, ML Boyett, JM Schuetz, EG Evans, WE
Citation: Mv. Relling et al., Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia, LANCET, 356(9226), 2000, pp. 285-290
Human cytochrome P450 maximal activities in pediatric versus adult liver
Authors: Blanco, JG Harrison, PL Evans, WE Relling, MV
Citation: Jg. Blanco et al., Human cytochrome P450 maximal activities in pediatric versus adult liver, DRUG META D, 28(4), 2000, pp. 379-382
Altered expression of hepatic cytochromes P-450 in mice deficient in one or more mdr1 genes. (vol 57, pg 188, 2000)
Authors: Schuetz, EG Umbenhauer, DR Yasuda, K Brimer, C Nguyen, L Relling, MV Schuetz, JD Schinkel, AH
Citation: Eg. Schuetz et al., Altered expression of hepatic cytochromes P-450 in mice deficient in one or more mdr1 genes. (vol 57, pg 188, 2000), MOLEC PHARM, 57(6), 2000, pp. NIL_1-NIL_1
Altered expression of hepatic cytochromes P-450 in mice deficient in one or more mdr1 genes
Authors: Schuetz, EG Umbenhauer, DR Yasuda, K Brimer, C Nguyen, L Relling, MV Schuetz, JD Schinkel, AH
Citation: Eg. Schuetz et al., Altered expression of hepatic cytochromes P-450 in mice deficient in one or more mdr1 genes, MOLEC PHARM, 57(1), 2000, pp. 188-197
CYP1A2 and CYP2D6 4-hydroxylate propranolol and both reactions exhibit racial differences
Authors: Johnson, JA Herring, VL Wolfe, MS Relling, MV
Citation: Ja. Johnson et al., CYP1A2 and CYP2D6 4-hydroxylate propranolol and both reactions exhibit racial differences, J PHARM EXP, 294(3), 2000, pp. 1099-1105
ELISA to evaluate plasma anti-asparaginase IgG concentrations in patients with acute lymphoblastic leukemia
Authors: Wang, B Hak, LJ Relling, MV Pui, CH Woo, MH Storm, MC
Citation: B. Wang et al., ELISA to evaluate plasma anti-asparaginase IgG concentrations in patients with acute lymphoblastic leukemia, J IMMUNOL M, 239(1-2), 2000, pp. 75-83
Topoisomerase II inhibitor-related acute myeloid leukaemia
Authors: Pui, CH Relling, MV
Citation: Ch. Pui et Mv. Relling, Topoisomerase II inhibitor-related acute myeloid leukaemia, BR J HAEM, 109(1), 2000, pp. 13-23
Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemia
Authors: Gajjar, A Harrison, PL Sandlund, JT Rivera, GK Ribeiro, RC Rubnitz, JE Razzouk, B Relling, MV Evans, WE Boyett, JM Pui, CH
Citation: A. Gajjar et al., Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemia, BLOOD, 96(10), 2000, pp. 3381-3384
Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus
Authors: Relling, MV Hancock, ML Rivera, GK Sandlund, JT Ribeiro, RC Krynetski, EY Pui, CH Evans, WE
Citation: Mv. Relling et al., Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus, J NAT CANC, 91(23), 1999, pp. 2001-2008
Risultati: 1-25 | 26-38